Rutaecarpine is a COX-2 inhibitor, and our study provides the first evidence of its relevance in the DR5 pathway.76 Etodolac, gossypol, and bropirimine exhibit an antitumor effect on several different cancer cells. Here, PTGS2 is linked to cancer.